Recovery and functionality of cryopreserved peripheral blood mononuclear cells using five different xeno-free cryoprotective solutions
Authors:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Cryobiology
- Vol. 86, 25-32
Abstract
No abstract availableKeywords
Funding Information
- Shenzhen Beike Biotechnology Co., Inc
This publication has 29 references indexed in Scilit:
- Virtual Global Transplant Laboratory Standard Operating Procedures for Blood Collection, PBMC Isolation, and StorageTransplantation Direct, 2016
- Cryoprotectant Toxicity: Facts, Issues, and QuestionsRejuvenation Research, 2015
- Defined serum- and xeno-free cryopreservation of mesenchymal stem cellsCell and Tissue Banking, 2014
- Preserving human cells for regenerative, reproductive, and transfusion medicineBiotechnology Journal, 2014
- NK cell-based immunotherapy for malignant diseasesCellular & Molecular Immunology, 2013
- Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based MediumBiopreservation and Biobanking, 2011
- An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cellsHuman Reproduction, 2010
- Evaluation of an automated closed fluid management device for processing expanded cytokine‐induced killer cells to use in immunotherapy programs for cancerTransfusion, 2008
- Improved vitrification solutions based on the predictability of vitrification solution toxicityCryobiology, 2004
- Mechanisms of Cryoinjury in Living CellsILAR Journal, 2000